{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:49:36Z","timestamp":1775947776254,"version":"3.50.1"},"reference-count":43,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antibodies to antigens of the GE (Gerbich) blood group system are not encountered in transfusion center blood banks on a daily basis but are regular guests at reference laboratories. In this review, we present an update on the information on GE antigens and alleles that have been published since the release of the previous system review in 2010. Additionally, information on the clinical relevance of GE antibodies for both transfusion and hemolytic disease of the fetus and newborn and recent discoveries related to functional aspects of the glycophorin C and glycophorin D proteins have been included.<\/jats:p>","DOI":"10.2478\/immunohematology-2026-005","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:33:12Z","timestamp":1775946792000},"page":"16-21","source":"Crossref","is-referenced-by-count":0,"title":["An update on the GE (Gerbich) blood group system"],"prefix":"10.2478","volume":"42","author":[{"given":"Peter C.","family":"Ligthart","sequence":"first","affiliation":[{"name":"Sanquin Diagnostics , Amsterdam , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbera","family":"Veldhuisen","sequence":"additional","affiliation":[{"name":"Sanquin Diagnostics , Amsterdam , the Netherlands"},{"name":"Sanquin Research , Amsterdam , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"2026041122330633744_j_immunohematology-2026-005_ref_001","doi-asserted-by":"crossref","unstructured":"Rosenfield RE, Haber GV, Kissmeyer-Nielsen F, Jack JA, Sanger R, Race RR. Ge, a very common red-cell antigen. Br J Haematol 1960;6:344\u20139.","DOI":"10.1111\/j.1365-2141.1960.tb06251.x"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_002","doi-asserted-by":"crossref","unstructured":"Walker PS, Reid ME. The Gerbich blood group system: a review. Immunohematology 2010;26:60\u20135.","DOI":"10.21307\/immunohematology-2019-204"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_003","unstructured":"ISBT Working Party Red Cell Immunogenetics and Blood Group Terminology. Gerbich [GE] system information. Available from https:\/\/blooddatabase.isbtweb.org\/system\/GE. Accessed 12 August 2025."},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_004","doi-asserted-by":"crossref","unstructured":"Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature 2021;596:583\u20139. doi: 10.1038\/s41586-021-03819-2.","DOI":"10.1038\/s41586-021-03819-2"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_005","doi-asserted-by":"crossref","unstructured":"Fleming J, Magana P, Nair S, et al. AlphaFold Protein Structure database and 3D-Beacons: new data and capabilities. J Mol Biol 2025;437:168967. doi: 10.1016\/j.jmb.2025.168967.","DOI":"10.1016\/j.jmb.2025.168967"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_006","doi-asserted-by":"crossref","unstructured":"Gassner C, Scherer V, Zanolin-Purin D, Scharberg EA, Flesch B. Occurrence of rare deletional Yus and Gerbich alleles in Syria and neighbouring countries. Transfus Med Hemother 2022;49:358\u201367. doi: 10.1159\/000524249.","DOI":"10.1159\/000524249"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_007","doi-asserted-by":"crossref","unstructured":"Patel SS, Mehlotra RK, Kastens W, Mgone CS, Kazura JW, Zimmerman PA. The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. Blood 2001;98:3489\u201391. doi: 10.1182\/blood.v98.12.3489.","DOI":"10.1182\/blood.V98.12.3489"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_008","doi-asserted-by":"crossref","unstructured":"Jaskiewicz E, Peyrard T, Kaczmarek R, Zerka A, Jodlowska M, Czerwinski M. The Gerbich blood group system: old knowledge, new importance. Transfus Med Rev 2018;32:111\u20136. doi: 10.1016\/j.tmrv.2018.02.004.","DOI":"10.1016\/j.tmrv.2018.02.004"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_009","doi-asserted-by":"crossref","unstructured":"Telen MJ, Le Van Kim C, Chung A, Cartron JP, Colin Y. Molecular basis for elliptocytosis associated with glycophorin C and D deficiency in the Leach phenotype. Blood 1991;78: 1603\u20136.","DOI":"10.1182\/blood.V78.6.1603.bloodjournal7861603"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_010","doi-asserted-by":"crossref","unstructured":"Reynolds MV, Vengelen-Tyler V, Morel PA. Autoimmune hemolytic anemia associated with autoanti-Ge. Vox Sang 1981;41:61\u20137. doi: 10.1111\/j.1423-0410.1981.tb01015.x.","DOI":"10.1159\/000460620"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_011","unstructured":"Lomas-Francis C, Tahiri T, Vege S, et al. GECT: a new high-prevalence antigen in the GE blood group system in a SCD patient with an apparent anti-GE2. Transfusion 2020;60(Suppl 5):7A\u2013260A."},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_012","unstructured":"Shakarian G, Ong J, Vege S, et al. A new antibody in the Gerbich blood system against a novel high prevalence antigen named GEAR. Transfusion 2016;56(Suppl 4):3A\u2013275A."},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_013","unstructured":"Poole J, Tilly, Hudler P, et al. Novel mutations in GYPC giving rise to lack of ge epitopes and anti Ge production. Vox Sang 2008;95(Suppl 1):181."},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_014","doi-asserted-by":"crossref","unstructured":"Jakobsen MA, Dellgren C, Sheppard C, Yazer M, Sprog\u00f8e U. The use of next-generation sequencing for the determination of rare blood group genotypes. Transfus Med 2019;29:162\u20138. doi: 10.1111\/tme.12496.","DOI":"10.1111\/tme.12496"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_015","doi-asserted-by":"crossref","unstructured":"Gleadall NS, Koets L, Shamardina O, et al. Array genotyping of transfusion relevant blood cell antigens in 6946 ancestrally diverse subjects. Blood 2025;146:1511\u201324. doi: 10.1182\/blood.2025028902.","DOI":"10.1182\/blood.2025028902"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_016","doi-asserted-by":"crossref","unstructured":"Gourri E, Denomme GA, Merki Y, et al. Genetic background of the rare Yus and Gerbich blood group phenotypes: homologous regions of the GYPC gene contribute to deletion alleles. Br J Haematol 2017;177:630\u201340. doi: 10.1111\/bjh.14578.","DOI":"10.1111\/bjh.14578"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_017","doi-asserted-by":"crossref","unstructured":"Petermann S, Mayer V, Carbol A, Opitz A, Flesch BK. Compound heterozygosity induces a rare Gerbich-negative phenotype in an immunized blood donor. Transfusion 2024;64:406\u201311. doi: 10.1111\/trf.17711.","DOI":"10.1111\/trf.17711"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_018","unstructured":"Mochizuki T, Tauxe WN, Ramsey G. In vivo crossmatch by chromium-51 urinary excretion from labeled erythrocytes: a case of anti-Gerbich. J Nucl Med 1990;31:2042\u20134."},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_019","doi-asserted-by":"crossref","unstructured":"Hildebrandt M, Hell A, Etzel F, Genth R, Salama A. Determination and successful transfusion of anti-Gerbich-positive red blood cells in a patient with a strongly reactive anti-Gerbich antibody. Infusionsther Transfusionsmed 2000; 27:154\u20136.","DOI":"10.1159\/000025261"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_020","doi-asserted-by":"crossref","unstructured":"Selleng S, Selleng K, Zawadzinski C, Wollert HG, Y\u00fcrek S, Greinacher A. Management of emergency cardiac surgery in a patient with alloanti-Ge2. Transfus Med 2009;19:50\u20132.","DOI":"10.1111\/j.1365-3148.2008.00900.x"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_021","doi-asserted-by":"crossref","unstructured":"Singh RP. Antibodies against high frequency Gerbich 2 antigen (anti-Ge2): a real challenge in cross matching lab. Asian J Transfus Sci 2013;7:88\u20139. doi: 10.4103\/0973-6247.106758.","DOI":"10.4103\/0973-6247.106758"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_022","unstructured":"ISBT Working Party Rare Donors. Outcome of antigen positive transfusion form. Available from www.isbtweb.org\/resource\/outcomeantigenpositivetransfusionform.html. Accessed 12 August 2025."},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_023","doi-asserted-by":"crossref","unstructured":"Baughn MR, Whitacre P, Lo GS, Pandey S, Lane TA. A mild acute hemolytic transfusion reaction in a patient with alloanti-Ge3: a case report and review of the literature. Transfusion 2011;51:1966\u201371. doi: 10.1111\/j.1537-2995.2011.03093.x.","DOI":"10.1111\/j.1537-2995.2011.03093.x"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_024","doi-asserted-by":"crossref","unstructured":"Wright T, Brown P, Marais I, Hong FS. Acute haemolytic reaction due to anti-Wb: a case report. Vox Sang 2013;105:355\u20137. doi: 10.1111\/vox.12052.","DOI":"10.1111\/vox.12052"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_025","doi-asserted-by":"crossref","unstructured":"Pate LL, Myers JC, Palma JP, et al. Anti-Ge3 causes late-onset hemolytic disease of the newborn: the fourth case in three Hispanic families. Transfusion 2013;53:2152\u20137. doi: 10.1111\/trf.12027.","DOI":"10.1111\/trf.12027"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_026","doi-asserted-by":"crossref","unstructured":"Levitt RN, Gourri E, Gassner C, et al. Molecular characterization and multidisciplinar y management of Gerbich hemolytic disease of the newborn. Pediatr Blood Cancer 2018;65:e27014. doi: 10.1002\/pbc.27014.","DOI":"10.1002\/pbc.27014"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_027","doi-asserted-by":"crossref","unstructured":"Arndt PA, Garratty G, Daniels G, et al. Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of ey throid progenitors. Transfus Med 2005;15:125\u201332. doi: 10.1111\/j.0958-7578.2005.00562.x.","DOI":"10.1111\/j.0958-7578.2005.00562.x"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_028","doi-asserted-by":"crossref","unstructured":"Blackall DP, Pesek GD, Montgomery MM, et al. Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody dependent hemolysis and erythroid precursor cell growth inhibition. Am J Perinatol 2008;25:541\u20135. https:\/\/doi.org\/10.1055\/s-0028-1085072.","DOI":"10.1055\/s-0028-1085072"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_029","unstructured":"Lomas-Francis C, Burgos A, Dombourian MG, et al. The first report of anti-Dha (anti-GE8) implicated in severe anemia of the fetus and newborn in two consecutive pregnancies. Vox Sang 2016;111(Suppl 1):46."},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_030","doi-asserted-by":"crossref","unstructured":"Klei TRL, de Back DZ, Asif PJ, et al. Glycophorin-C sialylation regulates Lu\/BCA M adhesive capacity during erythrocyte aging. Blood Adv 2018 3;2:14\u201324. doi: 10.1182\/bloodadvances.2017013094.","DOI":"10.1182\/bloodadvances.2017013094"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_031","doi-asserted-by":"crossref","unstructured":"Klei TRL, Dalimot JJ, Beuger BM, et al. The Gardos effect drives erythrocyte senescence and leads to Lu\/BCAM and CD44 adhesion molecule activation. Blood Adv 2020;4:6218\u201329. doi: 10.1182\/bloodadvances.2020003077.","DOI":"10.1182\/bloodadvances.2020003077"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_032","doi-asserted-by":"crossref","unstructured":"Tanaka S, Takakuwa Y. Intracellular interactions between protein 4.1 and glycophorin C on transport vesicles, as determined by fluorescence correlation spectroscopy. FEBS Lett 2012;586:668\u201374. doi: 10.1016\/j.febslet.2012.01.058.","DOI":"10.1016\/j.febslet.2012.01.058"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_033","doi-asserted-by":"crossref","unstructured":"Rydzak J, Kmiecik AM, Ja\u015bkiewicz E. [Human erythrocyte glycophorin C as the receptor for EBA-140 plasmodium falciparum merozoite ligand] (in Polish). Postepy Hig Med Dosw 2013;67:1331\u20139. doi: 10.5604\/17322693.1081865.","DOI":"10.5604\/17322693.1081865"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_034","doi-asserted-by":"crossref","unstructured":"Malpede BM, Lin DH, Tolia NH. Molecular basis for sialic acid-dependent receptor recognition by the Plasmodium falciparum invasion protein erythrocyte-binding antigen-140\/BAEBL. J Biol Chem 2013;288:12406\u201315. doi: 10.1074\/jbc. M113.450643.","DOI":"10.1074\/jbc.M113.450643"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_035","doi-asserted-by":"crossref","unstructured":"Ashline DJ, Duk M, Lukasiewicz J, Reinhold VN, Lisowska E, Jaskiewicz E. The structures of glycophorin C N-glycans, a putative component of the GPC receptor site for Plasmodium falciparum EBA-140 ligand. Glycobiology 2015;25:570\u201381. doi: 10.1093\/glycob\/cwu188.","DOI":"10.1093\/glycob\/cwu188"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_036","doi-asserted-by":"crossref","unstructured":"Rydzak J, Kaczmarek R, Czerwinski M, et al. The baculovirus-expressed binding region of Plasmodium falciparum EBA-140 ligand and its glycophorin C binding specificity. PLoS One 2015;10:e0115437. doi: 10.1371\/journal.pone.0115437.","DOI":"10.1371\/journal.pone.0115437"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_037","doi-asserted-by":"crossref","unstructured":"Jaskiewicz E, Jod\u0142owska M, Kaczmarek R, Zerka A. Erythrocyte glycophorins as receptors for Plasmodium merozoites. Parasit Vectors 2019;12:317. doi: 10.1186\/s13071-019-3575-8.","DOI":"10.1186\/s13071-019-3575-8"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_038","doi-asserted-by":"crossref","unstructured":"Lin E, Tavul L, Michon P, et al. Minimal association of common red blood cell polymorphisms with Plasmodium falciparum infection and uncomplicated malaria in Papua New Guinean school children. Am J Trop Med Hyg 2010;83:828\u201333. doi: 10.4269\/ajtmh.2010.09-0713.","DOI":"10.4269\/ajtmh.2010.09-0713"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_039","doi-asserted-by":"crossref","unstructured":"Lee WC, Malleret B, Lau YL, et al. Glycophorin C (CD236R) mediates vivax malaria parasite rosetting to normocytes. Blood 2014; 123:e100\u20139. doi: 10.1182\/blood-2013-12-541698.","DOI":"10.1182\/blood-2013-12-541698"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_040","doi-asserted-by":"crossref","unstructured":"Niang M, Bei AK, Madnani KG, et al. STEVOR is a Plasmodium falciparum erythrocyte binding protein that mediates merozoite invasion and rosetting. Cell Host Microbe 2014;16:81\u201393. doi: 10.1016\/j.chom.2014.06.004.","DOI":"10.1016\/j.chom.2014.06.004"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_041","doi-asserted-by":"crossref","unstructured":"Yiangou L, Montandon R, Modrzynska K, et al. A stem cell strategy identifies glycophorin C as a major erythrocyte receptor for the rodent malaria parasite Plasmodium berghei. PLoS One 2016;11:e0158238. doi: 10.1371\/journal. pone.0158238.","DOI":"10.1371\/journal.pone.0158238"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_042","doi-asserted-by":"crossref","unstructured":"Zerka A, Kaczmarek R, Czer winski M, Jaskiewicz E. Plasmodium reichenowi EBA-140 merozoite ligand binds to glycophorin D on chimpanzee red blood cells, shedding new light on origins of Plasmodium falciparum. Parasit Vectors 2017;10:554. doi: 10.1186\/s13071-017-2507-8.","DOI":"10.1186\/s13071-017-2507-8"},{"key":"2026041122330633744_j_immunohematology-2026-005_ref_043","doi-asserted-by":"crossref","unstructured":"Jajosky RP, Jajosky AN, Jajosky PG. Therapeutically-rational exchange (T-REX) of Gerbich-negative red blood cells can be evaluated in Papua New Guinea as \u201ca rescue adjunct\u201d for patients with Plasmodium falciparum malaria. Ther Apher Dial 2021;25:242\u20137. doi: 10.1111\/1744-9987.13551.","DOI":"10.1111\/1744-9987.13551"}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2026-005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:33:16Z","timestamp":1775946796000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2026-005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,10]]},"published-print":{"date-parts":[[2026,3,1]]}},"alternative-id":["10.2478\/immunohematology-2026-005"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2026-005","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}